
    
      Antiplatelet agents are important therapeutic options in treating patients with acute
      ischemic strokes to prevent recurrent ischemic events or death. The aim of this study was to
      evaluate the low-response prevalence of early antiplatelet therapy and the influence of
      different aspirin dosages in patients with acute ischemic strokes (AIS).
    
  